Filtered By:
Specialty: Rheumatology
Condition: Arthritis

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 260 results found since Jan 2013.

For Your Eyes Only: 007 Tips for the Management of Cardiovascular Risk Factors in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
J Rheumatol. 2023 Apr 15:jrheum.2023-0219. doi: 10.3899/jrheum.2023-0219. Online ahead of print.ABSTRACTPremature atherosclerosis has been observed during the course of different systemic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus, and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).1-3 As a result, cardiovascular (CV) events, including myocardial infarction, stroke, heart failure, coronary artery disease, and death, occur 1.65 to 3 times more commonly in patients with AAV as compared to the general population, and the risk appears to be highest in the firs...
Source: Journal of Rheumatology - April 15, 2023 Category: Rheumatology Authors: Jan Willem Cohen Tervaert Source Type: research

Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations
CONCLUSIONS: The prevalence of AH, T2D and CV diseases were higher in Italian patients rather than Belgians. Moreover, among patients with PsA, the risk of AH was higher in the Italian cohort compared to the Belgian cohort. These results suggest that further research is needed to evaluate potential extrinsic factors (geography and sociocultural aspects) that may contribute to CV risk.PMID:36826796 | DOI:10.55563/clinexprheumatol/aovika
Source: Clinical and Experimental Rheumatology - February 24, 2023 Category: Rheumatology Authors: Silvia Scriffignano Rik Lories Adrien Nzeusseu Toukap Ennio Lubrano Francesco Ciccia Serge Steinfeld Fabio Massimo Perrotta Ilenia Pantano Filip Van den Bosch Kurt de Vlam Source Type: research

Impact of targeted therapies on the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: A  systematic review and aggregate data meta‐analysis of randomized controlled trials
ConclusionCurrent targeted therapies are not associated with the risk of CVEs. Based on the existing evidence, we reported here that a dosage reduction of targeted therapies was not recommended.
Source: International Journal of Rheumatic Diseases - February 10, 2023 Category: Rheumatology Authors: Ruyi Cai, Yinji Jin, Beidi Chen, Jinxia Zhao, Jiayu Zhai, Lin Zeng, Rong Mu Tags: REVIEW Source Type: research

Epidemiology and survival of systemic sclerosis-sarcoidosis overlap syndrome
CONCLUSION: Sarcoidosis in SSc is rare but appears to occur more frequently than the general population. It is associated with pulmonary, lymph node, cutaneous, joint and hepatic involvement. Stroke occurs more frequently in SSc-sarcoidosis patients but with no differences in survival.PMID:36725057 | DOI:10.3899/jrheum.220877
Source: J Rheumatol - February 1, 2023 Category: Rheumatology Authors: Megan Himmel Meyer Balter Zareen Ahmad Elvira Bangert Shafina Hasmani Rhea Siddha Mohammad Movahedi Sindhu R Johnson Source Type: research